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Abstract 
One of the important issues in oncology is finding the genes that perturbation the cell functionality, and 
result in cancer propagation. The genes, namely driver genes, when they mutate in expression, result in 
cancer through activation of the mutated proteins. So, many methods have been introduced to predict this 
group of genes. These are mostly computational methods based on the number of mutations of each gene. 
Recently, some network-based methods have been proposed to predict Cancer Driver Genes (CDGs). In 
this study, we use a network-based approach and relative importance of each gene in the propagation and 
absorption of genes anomalies in the network to recognize CDGs. The experimental results are compared 
with 19 previous methods that show our proposed algorithm is better than the others in terms of accuracy, 
precision, and the number of recognized CDGs. 
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Section I  
Introduction to the Study  
 
 
Introduction 
Cancer is one of the serious challenges, and the researchers perform many efforts to cope with and treat it. 
With technology improvement and advanced tools of sequencing, a high amount of data has been obtained, 
and the disease treatment has been changed from a molecular approach to a network-based approach. In 
this approach, the disease is considered as a molecular system, and the goal is to find the anomalies that 
make perturbation in the total functionality of the system. One of the important issues in oncology is the 
detection of the cancer-causing genes [1]. In a cell, different components communicate with each other and 
create a biological system [2]. One of these systems is the gene regulatory network. In these networks, the 
effect of genes on each other leads to the change of the gene expression rate and protein production in the 
cell [3]. The change of a gene expression rate makes changes in the expression rate of other genes. The 
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expression rate of these genes and the changes should not get the cell functionality out of normal situations. 
A mutation in an expression rate of one or some of the genes and a problem in the cell's regulatory function, 
result in cancer. All the performed mutations don’t result in cancer, and some of the mutations named driver 
result in cancer. The driver mutations lead to activation of the mutated proteins that are involving in 
signaling paths. So the mutated proteins make the tumorigenesis induction and its survival. The genes that 
their mutations lead to cancer progression are Cancer Driver Genes (CDG). CDGs based on their role in 
disease is classified into Tumor suppressor genes or oncogenes. Different methods have been proposed to 
detect CDGs. Most of the proposed approaches are based on computational methods and use mutation 
concept such as ActiveDriver, OncodriverCLUST , e-Driver, Oncodrive-fm, Simon, Dendrix, CoMDP, 
MDPFinder,  MutSigCV, iPAC, MSEA, DrGap, r-Driver , and ExInAtor. In some of the previous 
techniques like DriverNet , NetBox , DawnRank, MeMo, and SCS in addition to mutation, network concept 
is used. Some other methods like iMaxDriver-N, iMaxdriver-w , and GHTS  use only the network for CDG 
recognition. In computational methods, based on analysis of the number of copies and gene expression data, 
a sequence of statistical tests is performed in a list of genes systematically to extract the cancer cells list. It 
means the driver genes are recognized through repetitive mutations in different tumor samples. The main 
challenge of these methods is the separation of cancer and non-cancer mutations. The problem is solved to 
some extent using the network and system approaches. For example, iMaxDriver methods use the 
maximization of the propagation approach in the network to predict cancer genes. GHTS detects the driver 
genes by modifying the web pages' search algorithms based on the biological data, gene expression, and 
calculation of each gene penetration rate. In MSEA, network features are used along with genomic and 
biologic features. DawnRank uses data interaction information to improve the performance of gene 
networks in addition to expression and mutation data. In Memo, CDGs recognition is performed based on 
the calculation of the correlation between genes and forming a network among the genes. DriverNet 
recognizes the driver genes by the relation between the genomic patterns and transcriptional data and 
analysis of the penetration network. So, the literature review shows that the previously proposed methods 
go from computational methods to the semi-networking and network-based methods, because of the 
performance improvement and using intrinsic features of molecular networks that are less considered in 
computational and mutation-based methods. 
Also, the mentioned computational and networking methods have some disadvantages. In most of the 
computational methods, the amount of false-positive is high, and precision and F-measure are low. 
Moreover, their performance in terms of the number of recognized CDG is not desirable. The network-
based methods, also, have some problems. For example, iMaxDriver-N and iMaxDriver-W have very high 
computational complexity, also weighting to the interactions is random, which is not a precise weighting 
method based on gene expression changes. Moreover, the method only recognizes TFs with the CDG role, 
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while some of the CDGs include mRNA. GHTS is another network-based method that solves the 
computational complexity and random weighting of iMaxDriver methods. It has better performance than 
other methods in terms of the number of detected CDGs and F-measure. But, it considers only the TFs with 
driver role without considering the part of mRNAs that are a component of CDG.  
In this research, a network-based algorithm called KatzDriver is proposed to recognize CDGs that can 
detect cancer-cause mRNAs along with cancer-cause TFs without the need for information on the biologic 
path and mutation data. Moreover, it eliminates the disadvantages of previous network-based methods and 
improves recognition performance. 
 
Study method 
Relative influence of a node in network 
 
In graph theory, there are different methods to calculate the effect of a node in a network. One of the 
methods is using the Katz measure to measure the amount of relative effect of a node in a social network 
[4]. Katz calculates the relative effect of a node in the network by measuring all of the walks between two 
nodes. While all of the network measures only consider the shortest path between two nodes, it can better 
show the relative importance of the nodes. So, it is similar to the PageRank algorithm of Google. Katz 
calculates the relative effect of a node in the network by measuring the number of direct neighbors and 
other nodes of the network that is connected to them through its direct neighbors. It is generalized centrality 
of eigenvector [5]. 
The relative effect of each node based on Katz centrality for node i is calculated through equation (1). 
𝐾𝑎𝑡𝑧𝑖 = 𝛼 ∑ 𝐴𝑖𝑗 .
𝑛
𝑗=0
𝐾𝑎𝑡𝑧𝑗 + 𝛽                    (1) 
Where A is the adjacency matrix. 𝛽 is used to prevent zero centrality and it is the weight that is assigned to 
direct neighbors. 𝛼 is the damping factor for the connections with distant neighbors that should be lower 
than the reverse of the highest Eigenvalue of the adjacency matrix to correct calculation of Katz centrality 
(𝛼 <
1
𝜆𝑚𝑎𝑥
). The difference between direct and indirect neighbors is determined using this parameter. In 
directed graphs, the centrality for a node is converted to two centralities of in-edges and out-edges. It shows 
the important of a node in the network in terms of influence power on the nodes and reception power from 
other nodes. It is defined by equations (2) and (3). 
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𝐾𝑎𝑡𝑧𝑖
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 = 𝛼 ∑ 𝐴𝑖𝑗 .
𝑛
𝑗=0
𝐾𝑎𝑡𝑧𝑗
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 + 𝛽                                   (2) 
𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 = 𝛼𝐴. 𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 + 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 − 𝛼𝐴. 𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 = 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠(𝐼 − 𝛼𝐴) = 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 = 𝜷. (𝐼 − 𝛼𝐴)−𝟏. 𝟏 
𝐾𝑎𝑡𝑧𝑖
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝛼 ∑ 𝐴𝑗𝑖 .
𝑛
𝑗=0
𝐾𝑎𝑡𝑧𝑗
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 + 𝛽                                        (3) 
𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝛼𝐴𝑇 . 𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 + 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 − 𝛼𝐴𝑇 . 𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠(𝐼 − 𝛼𝐴𝑇) = 𝜷 
𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝜷. (𝐼 − 𝛼𝐴𝑇)−𝟏. 𝟏 
𝑪𝐾𝑎𝑡𝑧
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝜷. (𝐼 − 𝛼𝐴𝑇)−𝟏. 𝟏 
 
 
KatzDriver Algorithm to CDGs Detection 
 
The studied network in this research is a transcription regulatory network. Such biological networks are 
obtained from the gene expression data. The nodes of the network are genes (including TFs and mRNAs), 
and the edges show the regulatory interactions between the nodes. There are two kinds of modules in these 
networks: gene modules and prescription modules. There are some genes in gene modules that all of them 
are regulated by one factor. In the prescription modules, there are some factors that all of them regulate 
common genes [3]. The regulatory interactions include TF-TFs and TF-mRNA.  
The driver genes consist of both prescription factors and mRNAs. According to the network structure, TFs 
mostly have influencial property, and mRNA genes mostly have receptional property, and both of them 
have a role in cancer propagation. In a regulatory gene network, the genes may change the expression of 
each other by the effect on each other. If these changes exceed the normal bound, it is mutated. If the 
mutation is performed in the driver genes, it leads to cancer. So, we can consider the genes with the highest 
relative impact as the driver genes. Because if they mutate, they will have the most impact on the 
perturbation in the cell regulatory functionality, anomaly propagation, and cancer occurrence. Hence, the 
genes can be ranked by calculation the amount of their influence and reception power, and introduced the 
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genes with highest scores as the cancer driver genes. We get two scores for each gene by modifying the 
Katz algorithm using the gene expression data and gene interactions weight. One is the relative effect of 
each gene in the gene regulatory network based on incoming interactions to it, and another one is the relative 
effect of each gene based on outgoing interactions from the gene. We called the new algorithm as 
KatzDriver. 
 
 Network Construction 
Gene regulatory interactions and expression data are needed to construct the network and applying the 
algorithm. For an accurate investigation of the results and show improvement of our method rather than 
GHTS, TRRUSTv2 database [6] is used to download the interactions list, and the GEO database is used to 
get gene expression data related to three cancers of colon, lung, and breast(Table 1). At first, weight is 
considered for each node using gene expression data using the Foldchange concept. Foldchange is a scale 
to determine the number of quantitative changes between the primary and secondary values of a variable, 
and it is considered as the rate between tow quantities. Foldchange means multifold. In other words, the 
considered gene expression in the first group samples (e.g., cancer samples) rather than the second group 
samples (e.g., normal samples) is multiplied or reduced several times [7]. If A and B are two values, and 
we want to calculate Foldchang for B based on the value of A, we should perform B/A. Foldchange is 
mostly performed when analysis of various measures of a biological system at different times. We extracted 
data related to gene expression of five patients in normal and cancer tissues for three cancers of breast, lung, 
and colon. Then we calculated the value of Foldchange for each gene by equation (4). 
𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒( 𝑔𝑒𝑛𝑒𝑖) =  
∑ 𝐶𝑒𝑥𝑝𝑔𝑒𝑛𝑒𝑖
5
𝑖=1
∑ 𝑁𝑒𝑥𝑝𝑔𝑒𝑛𝑒𝑖
5
𝑖=1
                                    (4) 
 
Then using the resulted values for each gene, we construct ?⃗? vector include foldchange values of genes. 
The weight of regulatory transactions can be calculated by minimizing the equation (5) that is proposed in 
GHTS. 
ℓ = 𝑀𝑖𝑛||𝐿𝑇 . 𝑣 − 𝑣||          ?⃗?: 𝑣𝑒𝑐𝑡𝑜𝑟  𝑜𝑓 𝑓𝑜𝑙𝑑𝑐ℎ𝑎𝑛𝑔𝑒 𝑣𝑎𝑙𝑢𝑒                                                      (5) 
 
Moreover, the initial score of the relative effect of each node is calculated based on the sum of the weights 
of outgoing edges and the sum of the incoming edges, and the value of Foldchange is calculated by (6). 
 
𝑖𝑛𝑠𝑡𝑎𝑟𝑡𝑔𝑒𝑛𝑒𝑖 = |𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒( 𝑔𝑒𝑛𝑒𝑖) × ( ∑ 𝑤𝑖𝑗
𝑗∈𝑜𝑢𝑡𝑒𝑑𝑔𝑒𝑠
− ∑ 𝑤𝑗𝑖
𝑗∈𝑖𝑛𝑒𝑑𝑔𝑒𝑠
)|               (6) 
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The relative value of the effect of each gene in the gene regulatory network computed through equations 
(7) and (8). 
𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑖
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 = 𝛼 ∑ 𝑤𝑖𝑗.
𝑛
𝑗=0
𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑗
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 + 𝛽                                                   (7) 
𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑖
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 = 𝛼 ∑ 𝑤𝑗𝑖.
𝑛
𝑗=0
𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑗
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠 + 𝛽                                                        (8) 
 
The considered values of 𝛼 and 𝛽 are 0.1 and 1, respectively. The values of incoming and outgoing relative 
importance are combined as equation (9), to obtain the final relative effect of each gene in the network. 
 
𝐾𝑇𝑍𝑑(𝑔𝑒𝑛𝑒𝑖) = 𝜆 × 𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑖
𝑜𝑢𝑡−𝑒𝑑𝑔𝑒𝑠 + (1 − 𝜆) × 𝐾𝑇𝑍𝑑𝑔𝑒𝑛𝑒𝑖
𝑖𝑛−𝑒𝑑𝑔𝑒𝑠                          (9) 
 
Where  0 < 𝜆 < 1 and it is used to regulate the amount of the two scores effects on the final score. If 𝜆 =
0, the resulted scores show only the amount of each gene's power for information propagation and based 
on the network structure, it recognizes the TF-type cancer driver genes. If 𝜆 = 1, the resulted scores show 
only the amount of each gene's power for information reception and based on the network structure, it 
recognizes the mRNA-type cancer driver genes. But, when the calculation of only outgoing or incoming 
power of each gene, the system has not its best performance. So, in this algorithm, 𝜆 is used as a trade-off 
for weighting between propagation and absorption powers of the genes anomalies. We expect that different 
values of 𝜆 are effective on the outcome performance. To select the best value of 𝜆 we used the area under 
the curve of ROC for each cancer with the values 𝜆 = 0, 𝜆 = 0.1, 𝜆 = 0.2, 𝜆 = 0.3, 𝜆 = 0.4, 𝜆 = 0.5, 𝜆 =
0.6, 𝜆 = 0.7, 𝜆 = 0.8, 𝜆 = 0.9, 𝑎𝑛𝑑 𝜆 = 1.0. Different values of AUC for breast, colon, and lung cancers 
are shown in figure 1. The higher level of the curve shows the model has a better distinction between cancer 
and non-cancer genes. The results show that in all the three mentioned cancer, when 𝜆 is zero, AUC has its 
lowest value. For 𝜆 = 1 its performance is in the middle rank, that is when only the ability of information 
propagation and reception of a gene is considered, the model performance is not good to detect the driver 
genes. By increment of 𝜆, AUC increases and it reaches its highest level, when 𝜆 = 0.9. This feature is for 
all the three mentioned kinds of cancer and 𝜆 = 0.9 is considered. In the next section, we show that the 
model has the best f-measure and the most recognition of CDGs, by considering  𝜆 = 0.9. 
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Figure 1: ROC curves of KatzDriver with different  𝜆. 
 
 
2-3 Data Processing and Evaluation Method 
 
Utilized data in this research include regulatory interactions to create gene regulatory network and gene 
expression values to create biological value to the nodes and the edges. The regulatory interactions list and 
data of gene expression are extracted from TRUUST V2 and GEO [8] databases, respectively, for breast, 
lung, and colon cancers. After preparation of the gene expression data and filtering extra interactions of the 
list, regulatory interactions of the considered network for the three mentioned cancer are constructed. Based 
on the mentioned methods in section 1-2-2, the nodes and the edges are weighted. Moreover, the Cancer 
Gene Census (CGC) list [9] is used to compare the results consisting of driver genes for the three types of 
cancer. In this dataset there are 572, 566 and 572 CDGs for breast, Lung and colon cancer respectively. 
Moreover, the results are compared with the driver genes of MSKCC , the driver genes introduced by 
Vogelstein et al., namely Mut-driver  and the driver genes introduced by Kumar et al., namely HiConf, to 
verify the results. In MSKCC There are 197, 397 and 423 CDGs for breast, Lung and colon cancer 
respectively. Mut-driver consist of 125 cancer driver genes. Also, HiConf consist of  99 CDGs. The set of 
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driver genes of MSKCC is downloaded from the cBioPortal database (https://www.cbioportal.org), and the 
driver genes of Mut-driver and HiConf are obtained from their related papers. 
F-measure, Recall, and Precision are used to evaluate the accuracy and precision of the proposed method. 
 
𝑅𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
                                     (10) 
𝑃𝑟𝑒𝑐𝑖𝑠𝑠𝑖𝑜𝑛 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
                          (11) 
 
𝐹 − 𝑚𝑒𝑎𝑠𝑢𝑟𝑒 = 2 ×
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 × 𝑅𝑒𝑐𝑎𝑙𝑙
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑅𝑒𝑐𝑎𝑙𝑙
                 (12) 
 
 
 
 
 
 
 
 
Figure 2: flowchart of KatzDriver algorithm 
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Section II  
Findings, Conclusions, and Recommendations 
 
 
 
Introduction 
 
This study was designed a network based approach, KatzDriver, to detect the cancer causal genes in gene 
regulatory network in human. We compared result of our method with 19 other computational and 
networking methods.This section includes the Findings, Conclusions, and Recommendations. 
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Findings 
Python programming language has been used for the implementation of the algorithm. Figure 2 shows the 
flowchart of the algorithm. By execution of the KatzDriver algorithm in each of the three cancer networks, 
an importance rank has been obtained for each gene that is a combination of its ability of propagation and 
information reception. Then ranked genes were sorted in descending order. The genes are classified 
into two groups of cancer factors and normal using a threshold value. The sklearn.metrics module has been 
used to fine-tuning the threshold value. Then f-measure and number of recognized CDGs by other methods 
are compared. The results of the proposed algorithm have been compared with the results of 18 
computational and networking models in [24] to show the accurate performance of the proposed improved 
algorithm.  
 
Figure 3 shows the results related to colon cancer. Two methods of comdp and memo have been removed 
from the diagram because of their zero values. As shown, KatzDriver has recognized 173 drivers for the 
colon cancer network, that it has the best performance among other network-based and computational (after 
ipac) methods. Moreover, it has the best performance among all the network-based and computational 
approaches by reaching f-measure=0.242. Figure 4 illustrates the comparison of KatzDriver with other 
methods for lung cancer network. We remove MDPfinder and memo methods because of their zero values. 
KatzDriver has the best performance among all the networking and computational methods similar to 
iMaxDriver-W by obtaining f-measure=0.242. Moreover, it has the first rank among the other 18 methods 
in this network by recognizing 155 drivers. The comparison of the proposed algorithm with other 
methods for the breast cancer network has been shown in figure 5. MDPfinder and comdp methods 
have been removed from the diagram due to their zero values. In this network, KatzDriver reaches 
f-measure=0.242 that has the best performance among other networking and computational 
methods. Moreover, it has recognized 152 drivers that has the best result among the network-based 
and computational methods after ipac. 
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  Figure 3: Results of KatzDriver with With 18 other methods for COAD network using CGC datasets. 
 
 
Figure 4: Results of KatzDriver with With 18 other methods for LUSC network using CGC datasets. 
 
 
Figure 5: Results of KatzDriver with With 18 other methods for BRCA network using CGC datasets. 
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Venn diagrams of the mentioned cancer networks have been shown in figure 9 for more comparison of the 
recognized CDGs by KatzDriver and other methods. KatzDriver can recognize 34% of all the recognized 
genes by all the computational methods for colon cancer. Moreover, it has recognized 55 genes that are not 
detected by any of the computational techniques. So, it can be a proper complementary method for 
computational methods. Also, KatzDriver has recognized 108 drivers for lung cancer that none of the 
computational methods can recognize that it is better than the network-based techniques of iMaxDriver-N, 
iMaxDrver-W, and GHTS. In breast cancer, KatzDriver recognizes 79 of the drivers that they cannot be 
detected by any of the computational methods. Besides, it has detected 14, 8, and 13 unique genes in colon, 
lung, and breast cancer networks that none of the computational and network-based approaches have 
recognized. The binary matrix illustration of the genes was detected as driver by computational and 
networking methods using CGC database is shown in figure 6. 
 
 
Figure 6: The binary matrix illustration of the genes was detected as driver by computational and 
networking methods using CGC. 
 
Figure 7: The binary matrix illustration of the genes was detected as driver by computational and 
networking methods using Mut-driver set. 
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Figure 8: The binary matrix illustration of the genes was detected as driver by computational and 
networking methods using MSKCC set. 
 
In addition to comparing the proposed method with the other methods using the CGC database in terms of 
the number of detected drivers and the fraction of detected drivers, for more validations we performed this 
comparison using the MSKCC dataset and the list of validated CDGs in Mut-driver and HiConf, as shown 
in table 2. For each of the validation datasets and each of the cancer type, top two approaches with the best 
detection results is shown as bold. In all of the cancer types, the KatzDriver is one of the top two approaches 
with the best results. In addition, the KatzDriver in all of the cancer types is better that the others network-
based methods. It should be noted that, most prediction methods are able to detect a limit number of CDGs. 
Although some of these method like iPac predict many CDGs, but it has not an acceptable accuracy, as its 
f-measure and precision shown in figures 3-5. 
Table 1: The data used to construct the network 
 
 
GE dataset(GEO) 
https://www.ncbi.nlm.nih.gov/geo/ 
 
Regulatory interactions (TRRUST) 
https://www.grnpedia.org/trrust/ 
 
GEO ID 
Cancer  
type 
Number 
of 
entries 
 
Number on 
interactions 
 
Number of  
genes 
GSE3268 Lung cancer 
(LUSC) 
22,284  
 
8,427 
 
# of TF 
genes 
 
# of non-
TF genes 
GSE32323 Colon 
cancer(COAD) 
54,675  
795 
 
2,067 
GSE15852 Breast cancer 
(BRCA) 
19,813 
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Table 2: The comparison result of KatzDriver with other methods useing CGC, MSKCC,HiConf and 
Mut-Driver datasets. 
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Figure 9: Venn diagrams of CDGs predicted by KatzDriver and other methods using CGC datasets. 
 
In addition, we compared the KatzDriver's with iMaxDriver-N, iMaxDrver-W, and GHTS network-based 
methods based on the overlap rate of the detected CDGs. Compare results shown in figure 10. It 
recognizes 94%, 76%, and 97% of the recognized drivers for colon cancer by iMaxDriver-N, iMaxDrver-
W, and GHTS, respectively. Moreover, it has detected 34 unique genes that cannot be recognized by three 
mentioned network-based methods. Also, KatzDriver has detected 94%, 73%, and 96% of the recognized 
drivers for lung cancer by iMaxDriver-N, iMaxDrver-W, and GHTS, respectively. For breast cancer, it has 
recognized 94%, 80%, and 94% of the recognized drivers by iMaxDriver-N, iMaxDrver-W, and GHTS, 
respectively. It has detected 22 unique genes that are not recognizable by the other three network-based 
methods. So it reaches the first rank among the network-based techniques. 
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Figure 10: Venn diagrams of CDGs predicted by KatzDriver and other network based methods using CGC 
datasets. 
 
Conclusion 
In this paper, we have proposed a network-based approach, namely KatzDriver, to recognize CDGs in the 
gene regulatory networks. It ranks the genes based on their relative importance for information propagation 
and reception. So, the genes with the highest effects on information propagation and reception, are the most 
effective ones in anomaly propagation in gene network and result in cancer propagation. In the 
preprocessing stage, the regulatory interactions are filtered, then the genes and the interactions are weighted 
based on biological data. The algorithm applied to three cancer network and the nodes are ranked. The 
genes with higher rank are more important and are classified as cancer genes. The results compared with 
18 computational and networking methods. The most advantages of the proposed algorithm are 
independence on genomic data and mutation, higher precision among all the network and computational 
methods, recognition of more CDGs, and no need for heavy calculations like iMaxDriver methods. In 
addition to the recognition of most of the detected genes by other network-based methods, KatzDriver has 
the best performance among other network-based methods by detection of some unique genes. Moreover, 
compare with other network-based methods, it can recognize more genes that are not predictable by 
computational approaches. Hence, it can be used as the best network-based method, along with 
computational prediction tools. As future work, to improve the performance of the proposed method can 
improve the regulatory interaction network to have more regulatory interactions. The ability to add other 
molecule elements of the cell regulatory network like miRNA to the interaction network is different based 
on the kind of regulatory interaction with TFs and miRNAs. The proposed approach can be used in other 
cell networks like gene-disease to find molecular treatments. 
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